Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-26-010413
Filing Date
2026-03-17
Accepted
2026-03-17 07:36:00
Documents
105
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K form10-k.htm   iXBRL 10-K 2736573
2 EX-3.3 ex3-3.htm EX-3.3 175992
3 EX-19 ex19.htm EX-19 72541
4 EX-21 ex21.htm EX-21 2647
5 EX-23.1 ex23-1.htm EX-23.1 3754
6 EX-31.1 ex31-1.htm EX-31.1 18642
7 EX-31.2 ex31-2.htm EX-31.2 19278
8 EX-32 ex32.htm EX-32 11380
9 EX-97 ex97.htm EX-97 64438
  Complete submission text file 0001493152-26-010413.txt   12917613

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE abeo-20251231.xsd EX-101.SCH 67545
11 XBRL CALCULATION FILE abeo-20251231_cal.xml EX-101.CAL 101653
12 XBRL DEFINITION FILE abeo-20251231_def.xml EX-101.DEF 289462
13 XBRL LABEL FILE abeo-20251231_lab.xml EX-101.LAB 625591
14 XBRL PRESENTATION FILE abeo-20251231_pre.xml EX-101.PRE 510139
108 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2459051
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 26759096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)